Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar + afatinib + S-1 for second-line advanced lung squamous cell carcinoma
ChiCTR2100050095Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jul 2021
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of endostar, afatinib and tegafur, sponsored by First Affiliated Hospital of Anhui Medical University. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
endostarafatinibtegafur
Beyond the preview
Go deeper on ChiCTR2100050095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050095.